Drug Discovery World

MARCH 13, 2023

Before 2019, CGT drug developers still had a young, academic mindset, ordering reagents, materials, and equipment haphazardly and assuming they would show up when needed. But now, the increased efficiency is likely making drug development cheaper. Planning—without hoarding resources—is everything.

Therapies 130

Therapies Drug Development Clinical Trials Cell Based Assays 130

Drug Discovery World

FEBRUARY 6, 2023

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care. Figure 2: Advanced data visualisation examples for transcriptomics data.

Bioinformatics 130

Bioinformatics RNA Vaccine Clinical Trials 130

Agency IQ

JUNE 9, 2023

Here, we’re starting some deeper analysis of aspects of the proposal package with a look at the impact of orphan drug provisions, seeing what impact the new provisions and the surrounding uncertainty might have on innovation. Orphan drug developers may set higher prices to recoup their return on investment lost due to the haircut.

Marketing 40

Marketing Biosimilars Regulations Drugs 40

Codon

JUNE 2, 2024

That is—until the Austrian monk Gregor Mendel showed that traits are passed from parent to offspring in discrete, independently assorted packages. While fundamental research is often productive in mice, translational drug research tends to be relatively intolerant to biological differences.

Laboratories 123

Laboratories Research Disease Science 123